Skye Bioscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Enrollment completed in Phase 2a CBeyond™ trial of CB1 inhibitor, nimacimab, in obesity and overweightFaster-than-expected enrollment enables ...
Artist Peter Sedgley, founder of Space Studios, dies aged 94 as tributes pour in
A pioneering figure in kinetic and optical art, Peter Sedgley was celebrated for his mesmerizing use of color and movement, ...
Oportun Comments on Letter from Findell Capital
SAN CARLOS, Calif., March 20, 2025 (GLOBE NEWSWIRE) -- Oportun (Nasdaq: OPRT), a mission-driven financial services company, today issued the following statement regarding a public letter from Findell ...